For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

The state government views Bhogapuram Airport not merely as an infrastructure project, but as a transformational asset for the entire North...

Prime Minister Narendra Modi will inaugurate the Alluri Sitarama Raju International Airport on August 1. This new airport is expected to bo...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...

Oil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...

Over the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...

As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...

In just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...

Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...

The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...

The acquisition is Eris’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies i...

Strides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.

TCG Lifesciences today said it has entered into an agreement with Austria-based JSW Lifesciences for collaboration services in clinical stu...

Lupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.

Ahmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...